Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT00367302
Eligibility Criteria:
Inclusion Criteria:
* opioid dependent patients who meet eligibility requirements for the KEEP program,
* patients serving sentences who will remain confined for at least 10 days but less than 90 days in the EMTC facility (all male) at Rikers,
* willingness to accept buprenorphine treatment,
* expected to reside in New York City after release
* 18-65 years of age
Exclusion Criteria:
* receiving methadone treatment in the community at sentencing and remanded to Rikers
* took non-prescribed 'street methadone' within last 3 days
* currently receiving more than 20mg/day methadone
* current psychotic symptoms (e.g., schizophrenia, schizoaffective disorder) requiring referral for mental health intervention, or current treatment with antipsychotic medication)
* HIV infection with T lymphocytes less than 200 per mm of blood and/or presence of a serious opportunistic infection requiring treatment, or receiving the HIV medication atazanavir.
* unable to complete English language interview
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00367302
Study Brief:
Protocol Section:
NCT00367302